SCHEMBL24742702

SCHEMBL24742702

C=CC(=O)N1CCN(Sc2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1

nearest known ligand 0.73

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 15/20 0.73
▸ PIK3CG P48736 15/20 0.73
▸ PIK3C2G O75747 14/20 0.73
▸ AURKA O14965 11/20 0.73
▸ AURKB Q96GD4 11/20 0.73
▸ BRD4 O60885 5/20 0.73
▸ PIK3CA P42336 4/20 0.73
▸ PIK3CB P42338 3/20 0.73
▸ PLK4 O00444 2/20 0.57
▸ LRRK2 Q5S007 2/20 0.57
▸ AURKC Q9UQB9 2/20 0.57
▸ NUAK1 O60285 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24742704 0.90 PIK3CD (0.73) PIK3CDPIK3CGPIK3C2GAURKAAURKB
SCHEMBL24742671 0.88 PIK3CD (0.65) PIK3CDPIK3CGPIK3C2GAURKAAURKB
SCHEMBL19457389 0.84 PIK3CD (1.00) PIK3CDPIK3CGPIK3C2GAURKAAURKB
SCHEMBL24742651 0.82 PIK3CD (0.58) PIK3CDPIK3CGPIK3C2GAURKAAURKB
SCHEMBL24742645 0.81 PIK3CD (0.73) PIK3CDPIK3CGPIK3C2GAURKAAURKB
SCHEMBL24743571 0.81 PIK3CD (0.73) PIK3CDPIK3CGPIK3C2GAURKAAURKB
SCHEMBL19457390 0.80 PIK3CD (1.00) PIK3CDPIK3CGPIK3C2GAURKAAURKB
SCHEMBL24742701 0.79 PIK3CD (0.76) PIK3CDPIK3CGPIK3C2GAURKAAURKB
SCHEMBL24742652 0.78 PIK3CD (0.58) PIK3CDPIK3CGPIK3C2GAURKAAURKB
SCHEMBL24742639 0.77 PIK3CD (0.57) PIK3CDPIK3CGPIK3C2GAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3440084-B1 PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING PI3K-MEDIATED DISORDERS DANA FARBER CANCER INST INC (US) 2022-12-21 — — EP disclosed
Send feedback